Research Article

Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX

Table 2

Patient characteristics.

ParametersFOLFOX4FOLFOX6mFOLFOX6FOLFOX7
No. of patients%No. of patients%No. of patients%No. of patients%

Gender
 Male1076.92975480675
 Female323.08325120225
Age: year
 Median63605167
 Range58–6452–6847–5349–72
ECOG performance status
 017.6918.330000
 1430.7718.33360225
 2753.851083.33240562.5
 317.690000112.5
Primary site
 Colon1076.92758.33240337.5
 Rectum323.08541.67120225
 Multiple0000240337.5
No. of sites
 1753.85433.33360675
 ≥2646.15866.67240225
AlkPO4
 Normal323.08650360562.5
 Increased753.85325240337.5
 Unknown323.083250000